The hepatotoxic compound bromobenzene binds to DNA, RNA, and proteins of rat and mouse liver in vivo. Binding to a significant extent is also detected in mouse kidney. The covalent binding index (CBI) of bromobenzene i s comparable to CBI values of moderately oncogenic substances. The enzyme-mediated in vitro interaction of bromobenzene with calf thyumus DNA and synthetic polyribonucleotides i s effected only by microsomes, especially those from mouse and rat liver. Microsomes from mouse lung are also efficient in bioactivating bromobenzene to interact with DNA. Among polyribonucleotides, poly(G) and poly(A) are the most labeled substrates. The suppression of binding to DNA by SKF 525-A and the induction of microsomal activity by a pretreatment with phenobarbitone in vivo confirm that bromobenzene i s bioactivated by a P-450 dependent-microsomal mixed function oxidase system. The covalent binding can be the main event to determine the possible carcinogenicity by genotoxic mechanisms. Bromobenzene is photoactivated by ultraviolet light (A = 254 nm) to forms capable of interacting with DNA in vitro; the binding is linear up to time.
INTRODUCTION
Bromobenzene is an environmental contaminant known to cause liver necrosis (17, 33) . This compound is, not hepatotoxic by itself, but it must be metabolized to a reactive form, presumably the 3,4-epoxide, capable of binding to liver proteins (17, 26, 41) . This reaction is mediated by a microsomal mixed function oxidase via cytochrome P-450 (20) . Moreover, a detoxification step has been detected through glutathione conjugation (27) . However, a simple correlation between hepatotoxicity of bromobenzene and protein binding did not emerge from all these studies. More recently, Casini et a1 (6) pointed out that lipid peroxidation plays a significant role in determining lethal cell injury and stated that the lipid peroxidation process could be the major cause for liver injury produced by Milan, Italy. Other chemicals, all of analytical grade, were obtained from Merck, Darmstadt, Germany.
Animals and Diet. Inbred adult male Wistar rats and BALB/c mice were obtained from Morini, S. Polo D'Enza, Italy and from Charles River, Calco, Italy, respectively. The animals were housed in macrolon cages at 22°C with 12-hr light and 12-hr darkness, receiving a standard pellet diet (Vogt-Moller, Piccioni, Brescia, Italy) and drinking water ad libitum.
In Vivo Studies: Binding to DNA, RNA, and Proteins. Four rats (-250 g) and 1 2 mice (-28 g) received intraperitoneally bromobenzene (127 pCi (6.35 pmol)/kg body weight) dissolved in dimethyl sulfoxide-sterile 0.9% NaCl solution (5:l) . Animals were killed and bled 22 hr after injection. They had been starved all through this period. Livers, kidneys, and lungs were removed, pooled, and processed as described elsewhere (24) in order to measure specific activity of DNA, RNA, and proteins.
In Vitro Studies: Enzyme-mediated Binding. Enzymatic fractions were extracted from rats and mice which had been pretreated with PB (100 mg/kg/day, dissolved in sterile 0.9% NaCl solution injected intraperitoneally) for 2 days prior to death. Microsomes and cytosols were obtained and stored as previously described (24) . The standard incubation mixture consisted of 2.5 pCi bromobenzene, 1.5 mg DNA or polynucleotide, 2 mg microsomal protein plus 2 mg NADPH or 6 mg cytosolic proteins plus 9.2 mg GSH to a final volume of 3 ml 0.08 M potassium phosphate-5 mM MgCl, buffer, pH 7.7. Reactions were carried out in duplicate or triplicate at 37°C in air for 60 min in the dark. The influence of various parameters (noninduced enzymes; time course; concentration of bromobenzene, enzymes, or DNA; addition of 1.5 mM SKF 525-A or of 10 mM GSH and/or cytosolic fractions to microsomal system) on binding extent was also tested. Blanks were systematically performed in the absence of cofactors. As further controls, some blanks were carried out in the absence of enzymes, with heat-inactivated enzymes, or at zero time incubation. Isolation, purification, and labeling determination of DNA, microsomal RNA, and proteins and of cytosolic proteins were performed as described by Mazzullo et a1 (24) .
Photoirradiation. Bromobenzene (12.5 pCi) and calf thymus DNA (7.5 mg) dissolved in 15 ml 0.08 M potassium phosphate buffer (pH 7.8) were poured into a closed spectrophotometric, 1-cm thick quartz cell and irradiated for 0, I, 2, and 3 hr at 22 f 0 2°C in air.
Photoirradiation was carried out either with low pressure (NN 15/44, X = 254 nm) or with mean pressure (Q-400, provided with a Sovi-re1 filter: X = 310-395 nm, A, , , = 365 nm) mercury vapor lamps. The incident fluence rate of the beam, measured by ferric oxalate actinometer (4) , was 84 J/cm'/min and 1790 J/cm'/min for X = 254 nm and A, , , = 365 nm, respectively. As a further control, a 3-hr incubation was performed in the dark under identical experimental conditions. At each time point, 1-ml aliquots were removed from the spectrophotometric quartz cell and DNA labeling was determined as previously described ( I ) . Assays were always in duplicate.
Statistical Analysis. Differences were analyzed by Student's t test with a level of cbnfidence of 95%. Table I shows the results obtained in in vivo interaction studies and the covalent binding index (CBI) values are also reported. Liver DNA labeling is the highest in both species. The binding to macromolecules of mouse kidney is far higher than that to rat kidney macromolecules. Negligible radioactivity is associated with lung DNA of both species. RNA labeling of assayed organs is always higher than DNA labeling. Interaction with proteins leads to steady binding values which are lower than RNA labelings and never inferior to those of DNA. shows the time course of microsome-mediated interactions of bromobenzene with DNA. Binding increased linearly up to 60 min of incubation and positive correlations were found between the extent of binding and the concentration of either tracer or microsomal protein, and a n inverse relationship was evident with the amount of DNA acceptor (data not shown). PB is a strong inducer of binding to proteins and RNA (2-Io-fold) and, mainly to DNA (20-fold) ( Table  11 ). Therefore, PB-induced fractions have been systematically employed as the standard procedure. With heat-inactivated microsomes or in the presence of SKF 525-A, bromobenzene binding to DNA is suppressed.
RESULTS
Values are similar to those of other blanks dpm/mg) and quite comparable to the chemical reactivity of bromobenzene per se (blanks of photoirradiation are reported in Table IV ). The addition of GSH or cytosolic enzymes to NADPH-containing standard microsomal system strongly inhibits the binding to DNA catalyzed by rat hepatic microsomes. When only hepatic cytosol is employed, the interaction of bromobenzene with DNA does not occur. Negligible values can be occasionally detected and the same phenomenon is observed with lung and kidney cytosols. Microsome-catalyzed binding of bromobenzene to DNA is mainly mediated by liver enzymes of both species (Table 111) . Mouse microsomes are slightly more efficient than rat microsomes. Also, lung microsomer from mouse are capable of bioactivating bromobenzene. Labeling of microsomal RNA and proteins is similar to those detected in liver fractions. Rat lung microsomes, as well as mouse and rat kidney microsomes, give rise to a negligible binding to DNA. Labeling of microsomal RNA and proteins is significantly' higher than that of DNA. Nevertheless, the pattern of interactions with microsomal constituents in the different organs is similar to that of binding to DNA. Interaction of bromobenzene with polyribonucleotides, catalyzed by microsomal enzymes from rat and mouse liver, shows a slight preference toward poly(A) and poly(G) (Fig. 2 ). Polynucleotide labeling is lower than DNA labeling, regardless of the microsomes employed.
Bromobenzene is photoactivated by irradiation with X = 254 nm to react with DNA.
Binding is near linear up to 3 hours (Table  IV) 
DISCUSSION
The extent of binding of bromobenzene to lung and kidney proteins gives evidence for acute toxicity in these organs besides in liver Each data point refers l o incubation of 2.5 pCi [U-"C]bromobenzene and 1.5 mg calf thymus DNA in 3 ml 0.08 M potassium phosphate buffer, p H 7.8, and represents mean of two net values, differing from each other in less than 7.0%: zero time irradiation binding values (blanks) (86 and 100 dpm/mg for X = 254 nm and A,, = 365 nm, respectively) have been taken off. The interaction occurring after 3-hr incubation in the dark was 146 and 180 dpm/mg for X = 254 n m and A,, = 365 nm, respect ively.
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Corresponding to 10 pmol/mg. (32, 34) . However, the chemical binds to DNA in liver more than in lung and kidney after intraperitoneal administration of a dosage which is lower than the minimal hepatotoxic dose of 1.8 mmol/kg (26) . The liver seems, therefore, to be a target also for bromobenzene genotoxicity. The CBI value, calculated on liver DNA labeling, is typical of initiators and higher than the index of cocarcinogens and promoters which are effective through nongenotoxic mechanisms (Table V) . Moreover, it is similar to the CBI of 1,a-dibromoethane (I), a chemical capable of inducing tumors in stomach, lung, spleen, and skin of rats and mice (16, 39) , and of oncogenic substances classified as moderately carcinogenic according to Lutz (22) (Table V) .
Irreversible binding of bromobenzene to DNA and macromolecular constituents of microsomes takes place in vitro via a P-450 dependent-microsomal mixed function oxidasc system. In fact, pretreatment of animals with PB, an inducer of cytochrome P-450, strongly enhances microsome-mediated binding. This has been demonstrated previously, with respect to protein binding alone in cell-free preparations (17, 20) and in hepatocytes (6) . The formation of bromobenzene 3.4-oxide is PB inducible and constitutes the intermediate involved in hepatic necrosis (1 8) . Pretreatment \v i t h 3 -me thy1 c hol a n t r en e protects against bromobenzene-induced hepatic necrosis via bromobcnzene 2,3-epoxide formation (19) . Enzymatic bioactivation of bromobenzene is confirmed by both micro-soma1 inactivation with heating and lack of enzyme-mediated interaction in the presence of SKI: 525-A. The direct relationship be- The hepatocarcinogenic effect of such oncogenic chemicals has not been proven up to now. Mouse liver instead of rat liver.
' A nonhepatocarcinogen able of inducing bladder tumors (CBI value in bladder DNA ~0.05).
moderate; in the tens, weak for initiators; below 1 for nongenotoxic oncogens (promotors and cocarcinogens).
tween extent of binding and concentration of tracer or microsomal protein further confirms that an enzymatic pathway is involved in the binding process. The addition of cytosolic fractions and/or GSH to NADPH-containing microsomal system strongly inhibits the extent of interaction with DNA. Therefore, an activation of the chemical by cytosolic pathway, seldom found as in the case of 1,2-dibromoethane, does not occur. Such a finding confirms the protective role of glutathione from attack by electrophilic alkylating metabolites to nucleophilic sites and suggests that the CBI of bromobenzene in vivo could be underestimated by the effectiveness of GSH conjugation occurring in liver. Indeed, the covalent binding of the toxic metabolite of bromobenzene to liver proteins was completely inhibited even at 0.1 M glutathione in vitro (41) , whereas the covalent binding of bromobenzene to liver proteins in vivo was detected mainly when liver glutathione concentration was less than 0.1 mM (171.. The strong inhibition of microsome-mediated binding by GSH suggests that not only the 3,4-oxide derivative of bromobenzene but also a phenolic metabolite is involved in the interaction process (14) . Catechol-like diphenols, such as the 3,4-diphenol, may be further oxidized to semiquinones and quinones by superoxide radical anions (38) . A participation of this oxygen radical is thus suggested by the effect of superoxide dismutase which inhibited the binding of bromobenzene by 50% (15) . Recent studies suggest that the oxidative stress determined by the generation of activated oxygen species and the subsequent lipid peroxidation may offer an alternative to covalent binding as an explanation of the biologic activity of many hepatotoxins. The interpretation of the role of lipid peroxidation in liver cell.injury by aryl halides could be more complex. It may be related to the depletion of GSH which renders the liver cell more susceptible to oxidative stress. Nevertheless, the covalent binding of electrophilic metabolites of hepatotoxins, such as bromobenzene, chlorobenzene, and iodobenzene, to nucleophilic sites of macromolecules is still considered to be the major mechanism of hepatotoxicity (9) . The microsome-mediated interaction of bromobenzene to DNA in vitro resembles that of 1,2-dibromoethane, a halogenated alkane recently studied by us under similar experimental conditions (8). Lung microsomes from mouse are strongly active in effecting the interaction with DNA of both bromobenzene and. 1,2-dibromoethane, whereas rat lung microsomes are inactive, and 1,2dibromoethane induces lung tumors in mice but not in rats (28) . The noticeable efficiency of hepatic microsomal system in bioactivating bromobenzene in vitro is in agreement with the pattern of in vivo binding. The comparison between in vivo and in vitro interactions shows some differences. The labeling of mouse kidney DNA is high, while microsomes from this organ are unable to mediate the in vitro interaction with DNA. They, however, catalyze the binding to microsomal RNA and proteins.
An opposite situation is seen with mouse lung since enzymatic fractions are very efficient in vifro, whereas the in vivo binding of bromobenzene with lung DNA is very low. It is probable that binding to kidney DNA in vivo is due to a reactive intermediate produced by hepatic microsomes with a stability sufficiently high to allow "at distance" effects (26) . In the case of mouse lung in vivo, the reactive forms locally produced by microsomes and intermediates produced by liver metabolism would not be able to penetrate into the nucleus and to interact with DNA. An interference by cytosolic pathway and/or the presence of GSH could also explain such a discrepancy. In conclusion, the evidence presented here shows that bromobenzene induces covalent binding to nucleic acids in in vivo and in vifro systems, providing unquestionable proof of its genotoxicity. Previous data from short-term assays were either marginally positive in a polA-test in the absence of activating system (36) . or negative in a morphologic transformation in the absence of metabolizing enzymes (29) , and in a n Ames test using Aroclor as inducer of microsomes (25) . Nevertheless, bromobenzene is not a direct alkylating agent and needs metabolic activation to show biologic effects. Also, the Aroclor induction of mixed function oxidase system resembles that of both PB and 3-methylcholantrene and the effect of the last polynuclear aromatic hydrocarbon on bromobenzene metabolism is quite opposite to that of PB. Therefore, the data now available suggest that long-term assays should be planned in order to detect the potential oncogenic action of bromobenzene since it is a halo derivate of benzene, a well-known carcinogen in humans and in animals. Bromobenzene is more active than the parent compound to covalently interact with nucleic acids in biologic systems (27) . There are already reports in the literature on chemicals which at first were found genotoxic in short-term tests and then oncogenic in long-term assays for carcinogenicity. Finally, the photo-induced binding of bromobenzene mediated by X = 254 nm might involve the formation of free radicals . as intermediates, related to its high c value at such wavelength due to the presence of a benzene ring in the molecule. In fact, nearultraviolet irradiation gives rise to a negligible binding, although a 21-fold higher incident fluence rate was used. Therefore, the environmental contaminant bromobenzene is activated to reactive forms by ultraviolet light like other carcinogens, such as dimethylnitrosamine (3) , and polycyclic aromatic hydrocarbons (30) regardless of the similarities of biologic and photochemical pathways involved in the interaction process which were confirmed (3) or not supported (30) . Thus, a possible risk for humans could exist since covalent binding to DNA is a crucial event in the process of chemical oncogenesis.
